Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator.
about
Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitorHepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitorSatellite cells in human skeletal muscle plasticityPurification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milkHepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironmentDistribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissuesGenomic structure and chromosomal localization of the human hepatocyte growth factor activator inhibitor type 1 and 2 genesIdentification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasinHepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placentaImmunohistochemical localization of hepatocyte growth factor activator (HGFA) in developing mouse liver tissues. Heterogeneous distribution of HGFA proteinNoncoding mutations of HGF are associated with nonsyndromic hearing loss, DFNB39.Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancersPericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA.Lessons from genetically engineered animal models. V. Knocking out genes to study liver regeneration: present and future.Combined paracrine and endocrine AAV9 mediated expression of hepatocyte growth factor for the treatment of renal fibrosisMechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.Met identification on human platelets: role of hepatocyte growth factor in the modulation of platelet activation.Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration.Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues.Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa.Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy.Proteomic analysis of white and yellow seminal plasma in turkeys (Meleagris gallopavo).Ontogeny of hepatocyte growth factor (HGF) and its receptor (c-met) in human placenta: reduced HGF expression in intrauterine growth restrictionThe molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing.Endothelin-3 stimulates survival of goblet cells in organotypic cultures of fetal human colonic epithelium.Identification of novel alternative splice isoforms of circulating proteins in a mouse model of human pancreatic cancer.Plasmin-mediated proteolysis is required for hepatocyte growth factor activation during liver repair.Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration.Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo.Hepatocyte growth factor activator (HGFA): a serine protease that links tissue injury to activation of hepatocyte growth factor.α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer.Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice.Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.An in vitro model for assessment of the biological activity of hepatocyte growth factor.Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo.Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation model.An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity.Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa.Role of fibroblasts in HGF/SF-induced cohort migration of human colorectal carcinoma cells: fibroblasts stimulate migration associated with increased fibronectin production via upregulated TGF-beta1.Characterization of membrane-associated prothrombin activator in normal and injured murine tissues.
P2860
Q24321843-FD5817D6-FFBD-463F-8872-0B8FCB87EE81Q24322087-7F3C3E7E-E232-482C-B8EA-1462D0C1AD6DQ26777962-934BF44C-01B2-43B3-9616-5AC433E2ECAAQ28137768-1FB5560B-6855-424D-824C-F933F5CD3960Q28140022-40070BA3-80A6-41EB-8B36-4B838FA043EEQ28142489-2D61755D-A125-45B6-8B1D-A80112A96D17Q28145050-E97B527A-03D5-4FA2-A505-A2AE331BEA71Q28267541-877672B6-8703-41BB-B4DD-43F461BD9856Q28588079-3756C304-5ED1-494F-9C83-AA234D031978Q28592355-37B18DCD-B863-40ED-9074-C27928BDF891Q30484106-4CE92BE5-54CB-40B2-80A0-91C6E70E4893Q31161402-CD7E429B-CDE0-4DD1-9F68-F37B1BD80809Q33518855-1FCB8BA2-E447-46E2-A02C-13FA5A80F28FQ33774773-F5A30FEF-47CA-478F-8A74-43F828458F01Q34025091-7C5EC046-3D16-41B9-BE89-78C9E95BC310Q34085432-7854C249-D957-44FB-A4A3-476C8E4E4CDDQ34440764-9918EC11-4E25-4FD0-ACF5-332CFD1DEBEDQ34592412-02AA1382-3AA1-4D3E-97B1-6F7A220C0AD5Q34997440-C88C30B5-77B5-4713-B274-091AB520FB4BQ35062087-BFCDDD1A-48E7-41DB-9383-51729DB704E9Q35595625-1AA877B5-987B-4258-83F2-22B67BB1905BQ35675760-19D6BF2D-5141-44E6-B712-C8F475F9F620Q35753572-3E877268-6EB1-4D80-9FAA-BBDE9D3F62FCQ36395707-53F7CCEB-5DA3-427E-A2BF-91E1C6DA7184Q37018321-17C249A4-0141-4AB6-AA67-162F35ABE652Q37036292-7B4791B0-C08D-4787-B5BD-4954A9320EECQ37176420-B32B33CC-BB3D-4AEB-AB2D-EAA980DB47A9Q37460349-9F4C5575-7AE8-42EC-99E1-D4A4C1518164Q37733681-1D9F089C-EBA9-4347-ACAB-6222A14DFE28Q37733689-7A3D98BF-1F6F-4B79-97EA-CD010391BBBAQ38793227-4533438F-60DD-4651-AB2D-8410C228EB92Q39850267-3B9D0DB3-C0CB-43C0-BE57-03F36EE92063Q40020532-066E93A5-2441-48E7-97F7-9B4B1180A77CQ40142003-A9F21860-FE1A-40C4-BD1F-7B48E8485D04Q40384156-C87774B3-33A6-47AC-B411-D0ADEA2A0869Q40561060-EB73AA68-8BF2-417E-A00C-1E5B711FFCC1Q40735252-F59E1EEC-292E-427F-9615-014BD41631A5Q40887379-DB5C5E0A-DF4F-4552-8DBC-4028BAAE895AQ40942820-05291DE1-9385-4597-8B48-EB5D5453F858Q41094837-19D514A9-6D30-411E-84EC-33BE107A75D3
P2860
Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator.
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Activation of hepatocyte growt ...... ocyte growth factor activator.
@ast
Activation of hepatocyte growt ...... ocyte growth factor activator.
@en
Activation of hepatocyte growt ...... ocyte growth factor activator.
@nl
type
label
Activation of hepatocyte growt ...... ocyte growth factor activator.
@ast
Activation of hepatocyte growt ...... ocyte growth factor activator.
@en
Activation of hepatocyte growt ...... ocyte growth factor activator.
@nl
prefLabel
Activation of hepatocyte growt ...... ocyte growth factor activator.
@ast
Activation of hepatocyte growt ...... ocyte growth factor activator.
@en
Activation of hepatocyte growt ...... ocyte growth factor activator.
@nl
P2860
P356
P1476
Activation of hepatocyte growt ...... tocyte growth factor activator
@en
P2093
N Kitamura
T Shimomura
P2860
P304
P356
10.1074/JBC.271.7.3615
P407
P50
P577
1996-02-01T00:00:00Z